ID   SH101-P4
AC   CVCL_A669
SY   SH101P4; SH-101-P4
DR   CGH-DB; 130-1
DR   CGH-DB; 9018-4
DR   Cosmic; 877039
DR   Cosmic; 897531
DR   Cosmic; 1122339
DR   Cosmic; 1187291
DR   Cosmic; 1518240
DR   JCRB; JCRB1944
DR   Wikidata; Q54953245
RX   PubMed=8242641;
RX   PubMed=15723654;
CC   Population: Japanese.
CC   Doubling time: 18 hours (PubMed=8242641).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): JCRB=JCRB1944
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 9
ST   D5S818: 13
ST   D7S820: 11,12
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RT29 ! SH101
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 11
//
RX   PubMed=8242641;
RA   Yanagihara K., Ito A., Toge T., Numoto M.;
RT   "Antiproliferative effects of isoflavones on human cancer cell lines
RT   established from the gastrointestinal tract.";
RL   Cancer Res. 53:5815-5821(1993).
//
RX   PubMed=15723654; DOI=10.1111/j.1349-7006.2005.00016.x;
RA   Takada H., Imoto I., Tsuda H., Sonoda I., Ichikura T., Mochizuki H.,
RA   Okanoue T., Inazawa J.;
RT   "Screening of DNA copy-number aberrations in gastric cancer cell lines
RT   by array-based comparative genomic hybridization.";
RL   Cancer Sci. 96:100-110(2005).
//